AAAAAA
Results: 1-25/41
Authors:
Mantsch, JR
Ho, A
Schlussman, SD
Kreek, MJ
Citation: Jr. Mantsch et al., Predictable individual differences in the initiation of cocaine self-ad ministration by rats under extended-access conditions are dose-dependent, PSYCHOPHAR, 157(1), 2001, pp. 31-39
Authors:
Zhou, Y
Unterwald, EM
Ho, A
LaForge, KS
Yuferov, VP
Kreuter, J
Sirianni, MJ
Allen, RG
Kreek, MJ
Citation: Y. Zhou et al., Ablation of pituitary pro-opiomelanocortin (POMC) cells produces alterations in hypothalamic POMC mRNA levels and midbrain mu opioid receptor bindingin a conditional transgenic mouse model, J NEUROENDO, 13(9), 2001, pp. 808-817
Authors:
Schluger, JH
Borg, L
Ho, A
Kreek, MJ
Citation: Jh. Schluger et al., Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction, NEUROPSYCH, 24(5), 2001, pp. 568-575
Authors:
Jacobsen, LK
Giedd, JN
Kreek, MJ
Gottschalk, C
Kosten, TR
Citation: Lk. Jacobsen et al., Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: a preliminary report, DRUG AL DEP, 62(1), 2001, pp. 49-56
Authors:
Yuferov, V
Zhou, Y
LaForge, KS
Spangler, R
Ho, A
Kreek, MJ
Citation: V. Yuferov et al., Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by "binge" pattern cocaine administration, BRAIN RES B, 55(1), 2001, pp. 65-70
Authors:
Zhou, Y
Spangler, R
Ho, A
Kreek, MJ
Citation: Y. Zhou et al., Hypothalamic CRH mRNA levels are differentially modulated by repeated 'binge' cocaine with or without D-1 dopamine receptor blockade, MOL BRAIN R, 94(1-2), 2001, pp. 112-118
Authors:
Cigler, T
LaForge, KS
McHugh, PF
Kapadia, SU
Leal, SM
Kreek, MJ
Citation: T. Cigler et al., Novel and previously reported single-nucleotide polymorphisms in the human5-HT(1B)receptor gene: No association with cocaine or alcohol abuse or dependence, AM J MED G, 105(6), 2001, pp. 489-497
Authors:
Butelman, ER
Ko, MCH
Traynor, JR
Vivian, JA
Kreek, MJ
Woods, JH
Citation: Er. Butelman et al., GR89,696: A potent kappa-opioid agonist with subtype selectivity in rhesusmonkeys, J PHARM EXP, 298(3), 2001, pp. 1049-1059
Authors:
LaForge, KS
Yuferov, V
Kreek, MJ
Citation: Ks. Laforge et al., Opioid receptor and peptide gene polymorphisms: potential implications foraddictions (vol 410, pg 249, 2001), EUR J PHARM, 426(1-2), 2001, pp. 145-145
Authors:
Butelman, ER
Kreek, MJ
Citation: Er. Butelman et Mj. Kreek, kappa-Opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D-2-like receptor agonists, EUR J PHARM, 423(2-3), 2001, pp. 243-249
Authors:
Unterwald, EM
Kreek, MJ
Cuntapay, M
Citation: Em. Unterwald et al., The frequency of cocaine administration impacts cocaine-induced receptor alterations, BRAIN RES, 900(1), 2001, pp. 103-109
Authors:
Mathieu-Kia, AM
Fan, LQ
Kreek, MJ
Simon, EJ
Hiller, JM
Citation: Am. Mathieu-kia et al., mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients, BRAIN RES, 893(1-2), 2001, pp. 121-134
Authors:
Perret, G
Deglon, JJ
Kreek, MJ
Ho, A
La Harpe, R
Citation: G. Perret et al., Lethal methadone intoxications in Geneva, Switzerland, from 1994 to 1998, ADDICTION, 95(11), 2000, pp. 1647-1653
Authors:
Schlussman, SD
Zhou, Y
Johansson, P
Kiuru, A
Ho, A
Nyberg, F
Kreek, MJ
Citation: Sd. Schlussman et al., Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat, NEUROSCI L, 284(3), 2000, pp. 190-194
Authors:
Quinones-Jenab, V
Krey, LC
Schlussman, SD
Ho, A
Kreek, MJ
Citation: V. Quinones-jenab et al., Chronic 'binge' pattern cocaine alters the neuroendocrine profile of pregnant rats, NEUROSCI L, 282(1-2), 2000, pp. 120-122
Authors:
LaForge, KS
Shick, V
Spangler, R
Proudnikov, D
Yuferov, V
Lysov, Y
Mirzabekov, A
Kreek, MJ
Citation: Ks. Laforge et al., Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: Potential in studies of addiction, AM J MED G, 96(5), 2000, pp. 604-615
Authors:
Zhou, Y
Franck, J
Spangler, R
Maggos, CE
Ho, A
Kreek, MJ
Citation: Y. Zhou et al., Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levelsafter acute, but not chronic, daily "binge" intragastric alcohol administration, ALC CLIN EX, 24(10), 2000, pp. 1575-1582
Authors:
Quinones-Jenab, V
Perrotti, LI
Mc Monagle, J
Ho, A
Kreek, MJ
Citation: V. Quinones-jenab et al., Ovarian hormone replacement affects cocaine-induced behaviors in ovariectomized female rats, PHARM BIO B, 67(3), 2000, pp. 417-422
Authors:
Quinones-Jenab, V
Perrotti, LI
Ho, A
Jenab, S
Schlussman, SD
Franck, J
Kreek, MJ
Citation: V. Quinones-jenab et al., Cocaine affects progesterone plasma levels in female rats, PHARM BIO B, 66(2), 2000, pp. 449-453
Authors:
Stimmel, B
Kreek, MJ
Citation: B. Stimmel et Mj. Kreek, Neurobiology of addictive behaviors and its relationship to methadone maintenance, MT SINAI J, 67(5-6), 2000, pp. 375-380
Authors:
Kling, MA
Carson, RE
Borg, L
Zametkin, A
Matochik, JA
Schluger, J
Herscovitch, P
Rice, KC
Ho, A
Eckelman, WC
Kreek, MJ
Citation: Ma. Kling et al., Opioid receptor imaging with positron emission tomography and [F-18]cyclofoxy in long-term, methadone-treated former heroin addicts, J PHARM EXP, 295(3), 2000, pp. 1070-1076
Authors:
Mantsch, JR
Schlussman, SD
Ho, A
Kreek, MJ
Citation: Jr. Mantsch et al., Effects of cocaine self-administration on plasma corticosterone and prolactin in rats, J PHARM EXP, 294(1), 2000, pp. 239-247
Authors:
LaForge, KS
Yuferov, V
Kreek, MJ
Citation: Ks. Laforge et al., Opioid receptor and peptide gene polymorphisms: potential implications foraddictions, EUR J PHARM, 410(2-3), 2000, pp. 249-268
Authors:
Butelman, ER
Harris, TJ
Kreek, MJ
Citation: Er. Butelman et al., Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serumprolactin levels in rhesus monkeys, PSYCHOPHAR, 147(1), 1999, pp. 73-80
Authors:
Butelman, ER
Vivian, JA
Yu, J
Kreek, MJ
Woods, JH
Citation: Er. Butelman et al., Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys, PSYCHOPHAR, 143(2), 1999, pp. 190-196